Evidence map›Paper›PMID 37022500›Full record

ReviewMikrochimica acta2023

Insight into continuous glucose monitoring: from medical basics to commercialized devices.

Ayman Chmayssem, Małgorzata Nadolska, Emily Tubbs, Kamila Sadowska, Pankaj Vadgma, Isao Shitanda, Seiya Tsujimura, Youssef Lattach, Martin Peacock, Sophie Tingry and 5 more

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Mikrochimica acta, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 4 countries.

Ayman ChmayssemUMR 5525, Univ. Grenoble Alpes, CNRS, Grenoble INP, INSERM, TIMC, VetAgro Sup, 38000, Grenoble, France.
Małgorzata NadolskaInstitute of Nanotechnology and Materials Engineering, Faculty of Applied Physics and Mathematics, Gdansk University of Technology, 80-233, Gdansk, Poland.
Emily TubbsUniv. Grenoble Alpes, CEA, INSERM, IRIG, 38000, Grenoble, Biomics, France.
Kamila SadowskaNalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Ks. Trojdena 4, 02-109, Warsaw, Poland.
Pankaj VadgmaSchool of Engineering and Materials Science, Queen Mary University of London, Mile End, London, E1 4NS, UK.
Isao ShitandaDepartment of Pure and Applied Chemistry, Faculty of Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan.
Seiya TsujimuraJapanese-French lAaboratory for Semiconductor physics and Technology (J-F AST)-CNRS-Université Grenoble Alpes-Grenoble, INP-University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8573, Japan.
Youssef LattachMADELECS, 77C, Avenue Jeanne d'Arc, 38100, Grenoble, France.
Martin PeacockZimmer and Peacock, Nedre Vei 8, Bldg 24, 3187, Horten, Norway.
Sophie TingryInstitut Européen Des Membranes, UMR 5635, IEM, Université Montpellier, ENSCM, CNRS, Montpellier, France.
Stéphane MarinescoPlate-Forme Technologique BELIV, Lyon Neuroscience Research Center, UMR5292, Inserm U1028, CNRS, Univ. Claude-Bernard-Lyon I, 69675, Lyon 08, France.
Pascal MailleyUniv. Grenoble Alpes, CEA, LETI, 38000, Grenoble, DTBS, France.
Sandrine LablancheUniv. Grenoble Alpes, LBFA and BEeSy, INSERM, U1055, F-38000, Grenoble, France.
Pierre Yves BenhamouDepartment of Endocrinology, Grenoble University Hospital, Univ. Grenoble Alpes, Pôle DigiDune, Grenoble, France.
Abdelkader ZebdaUMR 5525, Univ. Grenoble Alpes, CNRS, Grenoble INP, INSERM, TIMC, VetAgro Sup, 38000, Grenoble, France. abdelkader.zebda@univ-grenoble-alpes.fr.ORCID http://orcid.org/0000-0001-6616-5703
Inserm · FRInstitut polytechnique de Grenoble · FRCentre Hospitalier Universitaire de Grenoble · FRCentre National de la Recherche Scientifique · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRÉcole Nationale Supérieure de Chimie de Montpellier · FRGdańsk University of Technology · PLInstitute of Biocybernetics and Biomedical Engineering · PLQueen Mary University of London · GBTokyo University of Science · JPUniversité Claude Bernard Lyon 1 · FR

Funding

Campus France PARTENARIAT HUBERT CURIEN (PHC) Polonium grant 2021Institut Carnot LSI BIOEPC 2022 projectPolish National Agency for Academic Exchange PPN/BFR/2020/1/00052
6 · The paper itself

Abstract

According to the latest statistics, more than 537 million people around the world struggle with diabetes and its adverse consequences. As well as acute risks of hypo- or hyper- glycemia, long-term vascular complications may occur, including coronary heart disease or stroke, as well as diabetic nephropathy leading to end-stage disease, neuropathy or retinopathy. Therefore, there is an urgent need to improve diabetes management to reduce the risk of complications but also to improve patient's quality life. The impact of continuous glucose monitoring (CGM) is well recognized, in this regard. The current review aims at introducing the basic principles of glucose sensing, including electrochemical and optical detection, summarizing CGM technology, its requirements, advantages, and disadvantages. The role of CGM systems in the clinical diagnostics/personal testing, difficulties in their utilization, and recommendations are also discussed. In the end, challenges and prospects in future CGM systems are discussed and non-invasive, wearable glucose biosensors are introduced. Though the scope of this review is CGMs and provides information about medical issues and analytical principles, consideration of broader use will be critical in future if the right systems are to be selected for effective diabetes management.

Indexed as

Blood GlucoseDiabetes MellitusBlood Glucose Self-MonitoringGlucoseHumansBlood GlucoseGlucoseArtificial intelligenceBiosensorContinuous glucose monitoringDiabetes

Identifiers

PMID37022500
OpenAlexW4362657965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.